CMC life-cycle maintenance in broad portfolios | Expansion and licensing

A CMC dossier is usually seen as a regulatory asset. But in practice, it can also become a business enabler—or a bottleneck.

For companies managing broad portfolios of mature products or generics, dossier readiness has a direct impact on how efficiently they can support international expansion, licensing opportunities or third-party evaluations.

In this carousel, we share a few reflections on why CMC lifecycle maintenance matters not only for compliance, but also for portfolio usability and growth.